CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Granules India Limited Company Snapshot
Granules India Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Granules India Limited with three other companies in this sector in India: Laurus Labs Ltd (2019 sales of 22.92 billion Indian Rupees [US$321.56 million] of which 100% was Pharmaceutical Ingredients and intermedi), Natco Pharma Limited (20.95 billion Indian Rupees [US$293.86 million] of which 100% was Pharmaceuticals), and Pfizer Limited (20.82 billion Indian Rupees [US$292.03 million] of which 100% was Pharmaceuticals).

Sales Analysis. During the year ended March of 2019, sales at Granules India Limited were 22.79 billion Indian Rupees (US$319.77 million). This is an increase of 35.3% versus 2018, when the company's sales were 16.85 billion Indian Rupees.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Granules India Limited
  Stock Performance Chart for Granules India Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 120.10
(Figures in Indian Rupees)
1 Week -0.9%   13 Weeks 18.8%  
4 Weeks 24.5%   52 Weeks 14.1%  
 
Granules India Limited Key Data:
  Ticker: GRANULES Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 22,791,977,000
(Year Ending Jan 2020).
Employees: 4,220
  Currency: Indian Rupees Market Cap: 30,535,184,800
  Fiscal Yr Ends: March Shares Outstanding: 254,248,000
  Share Type: Ordinary Closely Held Shares: 122,413,232
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.